Inactive Instrument

MusclePharm Corporation Share Price Other OTC

Equities

Duration

Period

Style

Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	18/23/18	CI
FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	10/23/10	CI
Motion for Asset Sale Approved for MusclePharm Corporation	03/23/03	CI
FitLife Brands, Inc. entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.	27/23/27	CI
Stalking Horse Agreement Filed by MusclePharm Corporation	08/23/08	CI
Musclepharm Corporation Announces Resignation of Paul Karr as Director	01/23/01	CI
Second Amended Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	28/23/28	CI
First Amended Disclosure Statement Approved for MusclePharm Corporation	28/23/28	CI
Bidding Procedure Approved for MusclePharm Corporation	17/23/17	CI
Musclepharm Corporation Terminates Gary Shirshac as Chief Financial Officer	20/23/20	CI
First Amended Reorganization Plan and DIsclosure Statement Filed by MusclePharm Corporation	19/23/19	CI
Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	26/23/26	CI
Motion for Asset Sale Filed by MusclePharm Corporation	12/23/12	CI
First Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	10/23/10	CI
MusclePharm Corporation has withdrawn its IPO in the amount of $10 million.	16/23/16	CI

SEC Charges Former MusclePharm Executives with Accounting and Disclosure Fraud	28/23/28	AQ
MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	30/22/30	AQ
MusclePharm : Accelaration/Increase of Financial Obligation - Form 8-K	19/22/19	PU
MUSCLEPHARM CORP : Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement (form 8-K)	19/22/19	AQ
MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	24/22/24	AQ

Managers	Title	Age	Since
Eric Hillman CEO	Chief Executive Officer	-	13/23/13
Eric Chin DFI	Director of Finance/CFO	44	17/22/17
Ryan Charles Drexler CHM	Chairman	53	26/15/26

Members of the board	Title	Age	Since
Eric Hillman CEO	Chief Executive Officer	-	13/23/13
Michael Heller BRD	Director/Board Member	48	19/21/19
Ryan Charles Drexler CHM	Chairman	53	26/15/26

MusclePharm Corporation is a United States company. The Company has no operation nor generated any revenue.

Sector

Calendar

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+183.83%	6.83B
SCREAMING EAGLE ACQUISITION CORP.	+1.37%	1.01B
CHURCHILL CAPITAL CORP VII	+2.19%	982M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+22.49%	797M
ARES ACQUISITION CORPORATION II	+1.82%	664M
E7 GROUP	-1.80%	617M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ALTC ACQUISITION CORP.	+34.38%	592M